share_log

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

周一关注Enerpac工具集团、Singular Genomics Systems和3只股票
Benzinga ·  06/24 03:32

With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

今天早上美国股市期货略有上涨,今天可能受到投资者关注的一些股票如下:

  • Wall Street expects Enerpac Tool Group Corp. (NYSE:EPAC) to report quarterly earnings at 47 cents per share on revenue of $153.20 million after the closing bell. Enerpac Tool Group shares gained 1.9% to $39.22 in after-hours trading.
  • Singular Genomics Systems, Inc. (NASDAQ:OMIC) reported a 1-for-30 reverse stock split. Singular Genomics shares fell 9.3% to $0.3180 in the after-hours trading session.
  • Analysts are expecting Beyond Air, Inc. (NASDAQ:XAIR) to post a quarterly loss at $0.48 per share on revenue of $747.20 thousand. The company will release earnings after the markets close. Beyond Air shares gained 8.1% to $1.34 in after-hours trading.
  • 华尔街预计 Enerpac Tool Group Corp. (纽交所: EPAC) 将在收盘后以每股47美分的收益和1.532亿美元的营业收入发布季度财报。 Enerpac Tool Group 股票在盘后交易中涨1.9%至39.22美元。
  • Singular Genomics Systems, Inc. (纳斯达克: OMIC) 报告进行1比30的股票回购拆分。 Singular Genomics 股票在盘后交易中下跌9.3%,至0.3180美元。
  • 分析师预计 Beyond Air, Inc. (纳斯达克: XAIR) 将在每股0.48美元的亏损和74.72万美元的营业收入后发布季度财报。该公司将在市场收盘后发布财报。 Beyond Air 股票在盘后交易中涨8.1%,至1.34美元。

Check out our premarket coverage here

请查看我们的盘前报道。

  • Iteris, Inc. (NASDAQ:ITI) filed for a $150 million mixed securities shelf offering. Iteris shares fell 1.2% to $4.0201 in the after-hours trading session.
  • Stoke Therapeutics, Inc. (NASDAQ:STOK) said its Chief Operating Officer Huw Nash will step down, but will continue as Chief Business Officer, effective June 18. Stoke Therapeutics shares fell 3.6% to close at $14.23 on Friday.
  • Iteris, Inc. (纳斯达克: ITI) 提出了1.5亿美元的混合证券货架招股说明书。Iteris股票在盘后交易中下跌1.2%,至4.0201美元。
  • Stoke Therapeutics, Inc. (纳斯达克: STOK) 表示其首席运营官Huw Nash将退任,但将继续担任首席业务官,自6月18日起生效。 Stoke Therapeutics股票在上周五下跌3.6%,收于14.23美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发